Diuretic Drugs Market Growth, Trends, Absolute Opportunity and Value Chain 2018-2028

ROCKVILLE, United States, 2021-Mar-19 — /EPR Network/ —

Diuretic Drugs are also known as ‘water pills’. Diuretic drugs get rid of extra water in the body and lower blood pressure. Diuretic drugs are a class of drugs that increase the flow of urine in the body. They do so by reducing the sodium and chloride concentration in the body by removing it through the urine. This leads the body to draw excess water from the body. The sodium and chloride concentration in the body has a marked effect on the amount of water retained within the body. Hence, most of the diuretic drugs have their effects by reducing the body’s sodium and chloride content. Diuretic drugs are also used in combination along with various types of medications. They are useful in edema caused by renal dysfunction, and solely used as therapeutic agents to treat hypertension. As per the World Health Organization (WHO), increasing blood pressure accounts for an estimated 7.5 million deaths worldwide, and around 12.8% of the total deaths annually. Globally, the overall prevalence of blood pressure in adults aged over 25 was around 40% in 2008.

This Press Release will help you to understand the market Statistics of the European Region.
Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.factmr.com/connectus/sample?flag=S&rep_id=1500

Diuretic Drugs Market: Drivers and Restraints

The growing prevalence and recurrence of kidney stones, heart failure, and high blood pressure is expected to be the major factor driving the growth of the diuretic drugs market over the forecast period. According to the World Health Organization, cardiac disease is the number one cause of death, globally. An estimated 17.2 million people die from cardiac diseases, representing a total of 31% of global deaths annually. Approximately 7.4 million deaths were due to coronary heart disease, and approximately 6.7 million were due to stokes, which is expected to further drive the diuretic drugs market. Changes is lifestyle and eating habits are attributed to the growing prevalence of diuretic drugs. The launch and addition of new therapies is another factor contributing to the growth of the global diuretic drugs market.

Diuretic Drugs Market: Segmentation

Tentatively, the global diuretic drugs market can be segmented on the basis of product type, indication, distribution channel, and geography.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=1500

Based on product type, the global diuretic drugs market is segmented as:

Loop Diuretics
Thiazide Diuretics
Potassium-sparing Diuretics
Carbonic anhydrase Inhibitors
Based on indication, the global diuretic drugs market is segmented as:

Hypertension
Glaucoma
Heart Failure
Kidney Stones
Based on distribution channel, the global diuretic drugs market is segmented as:

Hospital Pharmacies
Independent Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Based on geography, the global diuretic drugs market is segment as:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan
Japan
Middle-East & Africa

To receive an extensive list of important regions, ask for TOC here- https://www.factmr.com/connectus/sample?flag=T&rep_id=1500

Diuretic Drugs Market: Overview

The global market for diuretic drugs is expected to witness moderate growth over the forecast period. A majority of the drugs are introduced in the generic market, and thus, there exists high competition among local and regional players. Amongst the four Diuretic drugs product types, the loop diuretic drugs segment is expected to lead the global diuretic drugs market over the forecast period. The pharmacies sub-segment under the distribution channel segment is expected to contribute a high share in the global diuretic drugs market, as it is the most accessible channel and a majority of patients are recommended Diuretic drugs.

Diuretic Drugs Market: Regional Outlook

Geographically, the global diuretic drugs market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global diuretic drugs market, owing to the high prevalence of the diuresis, edema and other diuretic anomalies. The diuretic drugs market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global diuretic drugs market throughout the forecast period.

Diuretic Drugs Market: Key Players

The global market for diuretic drugs is highly fragmented. Examples of some of the key players operating in the global diuretic drugs market are Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Meda Manufacturing GmbH, Valeant Pharmaceuticals International, Inc., Actavis Generics, Pfizer Inc., Merck & Co., Inc., Paddock Laboratories, LLC., and Perrigo Pharmaceuticals Company, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Tel: +1 (628) 251-1583
E: sales@factmr.com